Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$109M |
 |
Editas MedicineEDIT |
-$14M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| O'Day Daniel Patrick | Jan 23, 2026 | Sell | 115,640 | $135 | $16M |
| Bluestone Jeffrey | Jan 20, 2026 | Sell | 5,000 | $123.5 | $620,000 |
| Dickinson Andrew D | Jan 15, 2026 | Sell | 3,000 | $124.31 | $370,000 |
| Mercier Johanna | Jan 15, 2026 | Sell | 3,000 | $124.31 | $370,000 |
| O'Day Daniel Patrick | Dec 29, 2025 | Sell | 10,000 | $124.8272 | $1.2M |
| Dickinson Andrew D | Dec 15, 2025 | Sell | 3,000 | $122 | $370,000 |
| Mercier Johanna | Dec 15, 2025 | Sell | 3,000 | $122 | $370,000 |
| Kramer Kelly A. | Nov 28, 2025 | Sell | 2,805 | $127.1 | $360,000 |
| Bluestone Jeffrey | Nov 28, 2025 | Sell | 5,000 | $125.08 | $630,000 |
| O'Day Daniel Patrick | Nov 28, 2025 | Sell | 6,788 | $126.8438 | $860,000 |
| O'Day Daniel Patrick | Nov 28, 2025 | Sell | 3,212 | $125.9116 | $400,000 |
| Kramer Kelly A. | Nov 26, 2025 | Sell | 2,806 | $127.11 | $360,000 |
| Dickinson Andrew D | Nov 17, 2025 | Sell | 2,500 | $125.23 | $310,000 |
| Mercier Johanna | Nov 17, 2025 | Sell | 25,524 | $125.8251 | $3.2M |
| Mercier Johanna | Nov 17, 2025 | Sell | 2,476 | $126.2575 | $310,000 |
| Telman Deborah H | Nov 12, 2025 | Sell | 17,181 | $124 | $2.1M |
| Telman Deborah H | Nov 12, 2025 | Sell | 35,965 | $122.302 | $4.4M |
| Telman Deborah H | Nov 12, 2025 | Sell | 500 | $122.904 | $61,000 |
| O'Day Daniel Patrick | Oct 28, 2025 | Sell | 7,978 | $119.5371 | $950,000 |
| O'Day Daniel Patrick | Oct 28, 2025 | Sell | 2,022 | $118.8223 | $240,000 |
| Mercier Johanna | Oct 15, 2025 | Sell | 3,000 | $118.08 | $350,000 |
| Dickinson Andrew D | Oct 15, 2025 | Sell | 2,500 | $118.08 | $300,000 |
| O'Day Daniel Patrick | Sep 29, 2025 | Sell | 8,039 | $111.4703 | $900,000 |
| O'Day Daniel Patrick | Sep 29, 2025 | Sell | 1,961 | $112.4193 | $220,000 |
| Mercier Johanna | Sep 15, 2025 | Sell | 3,000 | $113.57 | $340,000 |
| Dickinson Andrew D | Sep 15, 2025 | Sell | 2,500 | $113.57 | $280,000 |
| O'Day Daniel Patrick | Aug 28, 2025 | Sell | 10,000 | $113.63 | $1.1M |
| Mercier Johanna | Aug 15, 2025 | Sell | 700 | $118.9686 | $83,000 |
| Mercier Johanna | Aug 15, 2025 | Sell | 11,800 | $118.5089 | $1.4M |
| Mercier Johanna | Aug 15, 2025 | Sell | 2,800 | $118.5074 | $330,000 |
| Mercier Johanna | Aug 15, 2025 | Sell | 200 | $118.965 | $24,000 |
| Dickinson Andrew D | Aug 15, 2025 | Sell | 2,500 | $118.53 | $300,000 |
| O'Day Daniel Patrick | Jul 28, 2025 | Sell | 8,345 | $114.0895 | $950,000 |
| O'Day Daniel Patrick | Jul 28, 2025 | Sell | 1,655 | $113.1678 | $190,000 |
| Mercier Johanna | Jul 15, 2025 | Sell | 3,000 | $111.03 | $330,000 |
| Dickinson Andrew D | Jul 15, 2025 | Sell | 2,500 | $111.03 | $280,000 |
| Bluestone Jeffrey | Jul 14, 2025 | Sell | 5,000 | $109.74 | $550,000 |
| O'Day Daniel Patrick | Jun 30, 2025 | Sell | 9,400 | $110.4038 | $1M |
| O'Day Daniel Patrick | Jun 30, 2025 | Sell | 600 | $111.1467 | $67,000 |
| Dickinson Andrew D | Jun 16, 2025 | Sell | 2,500 | $110.17 | $280,000 |
| Mercier Johanna | Jun 16, 2025 | Sell | 3,000 | $110.17 | $330,000 |
| O'Day Daniel Patrick | May 30, 2025 | Sell | 6,416 | $110.1148 | $710,000 |
| O'Day Daniel Patrick | May 30, 2025 | Sell | 3,584 | $110.9643 | $400,000 |
| Mercier Johanna | May 22, 2025 | Sell | 3,000 | $107.5212 | $320,000 |
| Mercier Johanna | May 22, 2025 | Sell | 12,500 | $107.5231 | $1.3M |
| Dickinson Andrew D | May 15, 2025 | Sell | 2,500 | $99.82 | $250,000 |
| Dickinson Andrew D | Apr 15, 2025 | Sell | 2,500 | $106.4 | $270,000 |
| Dickinson Andrew D | Mar 17, 2025 | Sell | 2,500 | $110.53 | $280,000 |
| Dickinson Andrew D | Mar 10, 2025 | Sell | 4,916 | $117.2988 | $580,000 |
| Dickinson Andrew D | Mar 10, 2025 | Sell | 13,013 | $118.5011 | $1.5M |
| Dickinson Andrew D | Feb 18, 2025 | Sell | 2,500 | $104.09 | $260,000 |
| Dickinson Andrew D | Feb 12, 2025 | Sell | 137,676 | $102.22 | $14M |
| Dickinson Andrew D | Jan 31, 2025 | Sell | 142,180 | $97.22 | $14M |
| Dickinson Andrew D | Jan 15, 2025 | Sell | 2,500 | $91.35 | $230,000 |
| Dickinson Andrew D | Dec 16, 2024 | Sell | 8,500 | $91.96 | $780,000 |
| Dickinson Andrew D | Nov 29, 2024 | Sell | 127,930 | $92.7626 | $12M |
| Dickinson Andrew D | Nov 29, 2024 | Sell | 120,715 | $92.7652 | $11M |
| Parsey Merdad | Nov 27, 2024 | Sell | 88,119 | $92 | $8.1M |
| Parsey Merdad | Nov 27, 2024 | Sell | 57,294 | $91.7949 | $5.3M |
| Parsey Merdad | Nov 27, 2024 | Sell | 5,200 | $91.8041 | $480,000 |
| Parsey Merdad | Nov 27, 2024 | Sell | 3,199 | $91.8034 | $290,000 |
| Parsey Merdad | Nov 27, 2024 | Sell | 10,399 | $92 | $960,000 |
| Bluestone Jeffrey | Nov 26, 2024 | Sell | 6,788 | $91.3901 | $620,000 |
| Parsey Merdad | Nov 6, 2024 | Sell | 20,590 | $91.5 | $1.9M |
| Parsey Merdad | Nov 6, 2024 | Sell | 5,000 | $91.5 | $460,000 |
| Mercier Johanna | Nov 6, 2024 | Sell | 5,000 | $91.28 | $460,000 |
| Parsey Merdad | Oct 1, 2024 | Sell | 2,000 | $83.83 | $170,000 |
| Parsey Merdad | Sep 12, 2024 | Sell | 21,246 | $84.5 | $1.8M |
| Mercier Johanna | Sep 12, 2024 | Sell | 15,925 | $84.23 | $1.3M |
| Mercier Johanna | Sep 12, 2024 | Sell | 13,432 | $83.25 | $1.1M |
| Mercier Johanna | Aug 28, 2024 | Sell | 9,513 | $78.03 | $740,000 |
| Mercier Johanna | Aug 13, 2024 | Sell | 5,490 | $73.98 | $410,000 |
| Parsey Merdad | Jul 1, 2024 | Sell | 2,000 | $68.63 | $140,000 |
| Parsey Merdad | Apr 1, 2024 | Sell | 2,000 | $72.96 | $150,000 |
| Parsey Merdad | Feb 29, 2024 | Sell | 8,230 | $72.7368 | $600,000 |
| Parsey Merdad | Feb 28, 2024 | Sell | 2,000 | $73.18 | $150,000 |
FAQ - Insider Transactions
The most recent insider transaction for Gilead Sciences was conducted by O'Day Daniel Patrick, who sold 115,640 shares on January 23, 2026 at a price of $135.00 per share.
Dickinson Andrew D has sold the most GILD stock in the last 2 years, with a total value of $58M.
The total value of insider transactions for Gilead Sciences in the last 2 years is negative, amounting to -$126M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Gilead Sciences have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
